aspirin has been researched along with pirenzepine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Guslandi, M | 1 |
| Londong, W | 1 |
| Hebzda, Z; Konturek, SJ; Kwiecien, N; Obtulowicz, W; Oleksy, J | 1 |
| Ariizumi, M; Egawa, K; Iwasaki, H; Kameda, H; Kawamura, T; Nozawa, H; Onizawa, N; Takayama, S; Torii, A | 1 |
| Brzozowski, T; Konturek, SJ; Piastucki, I; Radecki, T | 1 |
| Daniotti, S; Del Soldato, P; Ferrante, F; Foschi, D; Rovati, V; Varin, L | 1 |
| Gastfriend, DR; Sattar, SP | 1 |
1 trial(s) available for aspirin and pirenzepine
| Article | Year |
|---|---|
Effects of protective drugs on gastric alkaline secretion in man.
Topics: 16,16-Dimethylprostaglandin E2; Adult; Antacids; Aspirin; Atropine; Bicarbonates; Gastric Mucosa; Humans; Pirenzepine; Sucralfate | 1987 |
9 other study(ies) available for aspirin and pirenzepine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Can acid inhibitors be "true" cytoprotective agents?
Topics: Animals; Aspirin; Benzodiazepinones; Disease Models, Animal; Ethanol; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Pirenzepine | 1985 |
Anti-ulcer drugs in antisecretory doses for "cytoprotection" in arthritic patients?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Aspirin; Histamine H2 Antagonists; Humans; Peptic Ulcer; Pirenzepine; Prostaglandins | 1986 |
[Histochemical examination of gastric covering and epithelial mucus in rats (the 2nd report). Effect of several anti-ulcer drugs on aspirin-induced mucosal damage].
Topics: Animals; Anti-Ulcer Agents; Aspirin; Benzodiazepinones; Cimetidine; Dinoprostone; Gastric Mucosa; Male; Pirenzepine; Prostaglandins E; Rats; Rats, Inbred Strains | 1985 |
Gastric cytoprotection by pirenzepine. Role of endogenous prostaglandins.
Topics: Animals; Aspirin; Benzodiazepinones; Dinoprostone; Gastric Acid; Gastric Mucosa; Male; Pirenzepine; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains | 1982 |
Cytoprotection by PGE2, atropine, pirenzepine and vagotomy in rats.
Topics: Animals; Aspirin; Atropine; Benzodiazepinones; Dinoprostone; Female; Gastric Mucosa; Pirenzepine; Prostaglandins E; Rabbits; Rats; Rats, Inbred Strains; Vagotomy | 1982 |
Visual inspection of medications in preventing unexplained relapses.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Aspirin; Benzodiazepines; Cetirizine; Clonazepam; Depression; Female; Humans; Medication Errors; Middle Aged; Olanzapine; Pirenzepine; Secondary Prevention; Terminology as Topic | 2002 |